TipRanks
Advertisement
Advertisement

QNCX Stock Latest News

Quince Relaunches as IRulya Therapeutics with New Leadership
Company AnnouncementsQuince Relaunches as IRulya Therapeutics with New Leadership
3d ago
8K
QNCX
Quince Therapeutics changes name to IRulya Therapeutics
PremiumThe Fly
Quince Therapeutics changes name to IRulya Therapeutics
3d ago
QNCX
Quince Therapeutics initiated with an Outperform at Raymond James
PremiumThe Fly
Quince Therapeutics initiated with an Outperform at Raymond James
3d ago
QNCX
Quince Shareholders Approve New Equity and Stock Plans
PremiumCompany Announcements
Quince Shareholders Approve New Equity and Stock Plans
6d ago
8K
QNCX
Quince Therapeutics Announces Conditional Board Restructuring Plans
PremiumCompany Announcements
Quince Therapeutics Announces Conditional Board Restructuring Plans
10d ago
8K
QNCX
Analyst Reiterates Buy on Quince Therapeutics, Maintaining Unchanged $98 Price Target Amid Advancing Pulmonary Pipeline
PremiumRatingsAnalyst Reiterates Buy on Quince Therapeutics, Maintaining Unchanged $98 Price Target Amid Advancing Pulmonary Pipeline
12d ago
QNCX
CoreWeave upgraded, Etsy downgraded: Wall Street’s top analyst calls
Premium
The Fly
CoreWeave upgraded, Etsy downgraded: Wall Street’s top analyst calls
18d ago
O
CG
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
18d ago
QNCX
Netflix downgraded, SanDisk initiated: Wall Street’s top analyst calls
PremiumThe Fly
Netflix downgraded, SanDisk initiated: Wall Street’s top analyst calls
20d ago
EG
EAT
Quince Therapeutics upgraded to Outperform from Market Perform at Citizens
PremiumThe Fly
Quince Therapeutics upgraded to Outperform from Market Perform at Citizens
20d ago
QNCX
Quince Therapeutics Divests Italian Subsidiary, Refocuses Strategy
PremiumCompany Announcements
Quince Therapeutics Divests Italian Subsidiary, Refocuses Strategy
28d ago
8K
QNCX
Quince Therapeutics Faces Nasdaq Listing Compliance Challenges
PremiumCompany Announcements
Quince Therapeutics Faces Nasdaq Listing Compliance Challenges
1M ago
8K
QNCX
Quince Therapeutics Announces Planned Presidential Leadership Transition
PremiumCompany AnnouncementsQuince Therapeutics Announces Planned Presidential Leadership Transition
2M ago
8K
QNCX
Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy
Premium
The Fly
Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy
2M ago
QNCX
Quince Therapeutics initiated with a Buy at Craig-Hallum
Premium
The Fly
Quince Therapeutics initiated with a Buy at Craig-Hallum
2M ago
QNCX
Quince Plans Shareholder Vote on Major Stock Issuance
PremiumCompany Announcements
Quince Plans Shareholder Vote on Major Stock Issuance
2M ago
8K
QNCX
Quince Therapeutics participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Quince Therapeutics participates in a conference call with Cantor Fitzgerald
2M ago
QNCX
Quince Therapeutics reports Q2 EPS ($12.31), consensus ($12.39)
PremiumThe Fly
Quince Therapeutics reports Q2 EPS ($12.31), consensus ($12.39)
2M ago
QNCX
Morning Movers: Applied Materials slips after quarterly earnings
PremiumThe Fly
Morning Movers: Applied Materials slips after quarterly earnings
2M ago
W
FOX
QNCX Earnings this Week: How Will it Perform?
PremiumPre-EarningsQNCX Earnings this Week: How Will it Perform?
2M ago
QNCX
Quince Therapeutics management to meet with Oppenheimer
Premium
The Fly
Quince Therapeutics management to meet with Oppenheimer
2M ago
QNCX
Quince Therapeutics Announces Leadership Transition to Orphai Team
Premium
Company Announcements
Quince Therapeutics Announces Leadership Transition to Orphai Team
2M ago
8K
QNCX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >